Supplier

ROCHE SRO

Value won

CZK 769.2m

Across 4 contracts won

A Czech Republic supplier, with 4 awarded contracts, most recently 6 months ago.

Czech Republic(inferred)

Value won

CZK 769.2m

Across 4 contracts won

Contract history

4 entries

Most recent
19 Feb 2026
6 months ago
Biggest
CZK 396.2m
Supply of Pharmaceuticals and Medic…
Average size
CZK 192.3m
Across 4 priced
Last 12 months
1
entry

Won · 4

Dynamic Purchasing System for Pharmaceutical SuppliesCZK 38,707,200 · 19 Feb 2026 Supply of Risdiplam for Musculoskeletal System TreatmentsCZK 324,591,840 · 19 Jun 2025 Supply of Pharmaceuticals and Medical DevicesCZK 9,788,991 · 5 Jun 2025 Supply of Pharmaceuticals and Medical DevicesCZK 396,160,211 · 19 May 2025

May 25Jul 25Oct 25Dec 25Mar 26

Opportunities

Showing awarded · 4

AwardedHealthcare & MedicalCzech Republic

Dynamic Purchasing System for Pharmaceutical Supplies

This procurement opportunity involves the establishment of a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products primarily for the Pharmacy of the Faculty Hospital in Olomouc. The aim is to have a wide range of suppliers who will be invited to submit bids for individual public

CZK 38,707,200FACULTY HOSPITAL OLOMOUC

Published 19 Feb 2026

AwardedHealthcare & MedicalCzech Republic

Supply of Risdiplam for Musculoskeletal System Treatments

This public procurement contract involves the ongoing supply of a medicinal product containing the active ingredient risdiplam (ATC M09AX10). The required formulation is 0.75MG/ML in powder for solution, with a unit measure of 1+AD+5XSTŘ, totaling a quantity of 2,400 units. The contract is valued at

CZK 324,591,840THOMAYER HOSPITAL

Published 19 Jun 2025

AwardedHealthcare & MedicalCzech Republic

Supply of Pharmaceuticals and Medical Devices

This public procurement contract involves the ongoing supply of pharmaceuticals containing the active ingredients Oseltamivir (J05AH02) and Mycophenolic Acid (L04AA06), including Cellcept, for a duration of 4 years. The total value of the contract is approximately €9,788,990.52. The contract is issu

CZK 9,788,991UNIVERSITY HOSPITAL ST ANNE IN BRNO

Published 5 Jun 2025

AwardedHealthcare & MedicalCzech Republic

Supply of Pharmaceuticals and Medical Devices

This public procurement contract involves the ongoing supply of pharmaceuticals containing the active ingredients L04AC07 Tocilizumab (Roactemra) and L04AG08 Okrelizumab for a duration of 4 years. The contracting authority requires only those pharmaceuticals for which the State Institute for Drug Co

CZK 396,160,211UNIVERSITY HOSPITAL ST ANNE IN BRNO

Published 19 May 2025